î
îŒ
î
LAVA Therapeutics NV
LVTXî¹
詳现ãã£ãŒãã衚瀺
1.740USD
0.0000.00%
çµå€Â 02/06, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
45.77Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
Intraday
1m
30m
1h
D
W
M
D
æ¬æ¥
0.00%
5æ¥é
0.00%
1ã¶æ
0.00%
6ã¶æ
+13.73%
幎åæ¥
0.00%
1幎é
+84.13%
詳现ãã£ãŒãã衚瀺
TradingKey æ ªåŒã¹ã³ã¢
ããŒã¿ãäžååãªãããæ ªåŒã¹ã³ã¢ã¯å©çšã§ããŸããã
LAVA Therapeutics NV ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
財åææšî
EPS
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
LAVA Therapeutics NVã®äŒæ¥æ å ±î
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
äŒæ¥ã³ãŒãLVTX
äŒæ¥åLAVA Therapeutics NV
æé«çµå¶è²¬ä»»è
ãCEOãMr. Stephen A. Hurly
ãŠã§ããµã€ãhttps://www.lavatherapeutics.com/
é¢é£éèåå
+3.66%
+3.17%
+0.93%
+1.99%
+1.78%
+1.60%
-0.95%
+4.49%
+2.10%
+10.00%
+2.72%
+4.15%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%人æ°éæ
278.120
+2.210Â (+0.80%)
185.410
+13.530Â (+7.87%)
67843.990
-2126.140Â (-3.04%)
282.580
+22.390Â (+8.61%)
2007.410
-44.320Â (-2.16%)
411.110
+13.900Â (+3.50%)
4952.980
+142.360Â (+2.96%)
63.303
+0.206Â (+0.33%)
1.182
+0.004Â (+0.35%)
157.098
+0.057Â (+0.04%)
